Details for New Drug Application (NDA): 006309
✉ Email this page to a colleague
NDA 006309 describes KWELL, which is a drug marketed by Reed And Carnrick and is included in four NDAs. Additional details are available on the KWELL profile page.
The generic ingredient in KWELL is lindane. There are two drug master file entries for this compound. Additional details are available on the lindane profile page.
The generic ingredient in KWELL is lindane. There are two drug master file entries for this compound. Additional details are available on the lindane profile page.
Summary for 006309
| Tradename: | KWELL |
| Applicant: | Reed And Carnrick |
| Ingredient: | lindane |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 006309
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | LOTION;TOPICAL | Strength | 1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
